Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

1.6K
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
1.6K
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

1.6K
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.6K
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

1.5K
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.5K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

1.4K
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
1.4K
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

923
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
923
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

2.0K
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diverging incidences of low-grade dysplasia and advanced neoplasia in inflammatory bowel disease: a nationwide Danish cohort study.

Scandinavian journal of gastroenterology·2026
Same author

Cultural adaptation and validation for Brazilian portuguese of the MENTOR tool: monitoring the efficacy of neurogenic bowel treatment.

Spinal cord·2026
Same author

Effects of non-invasive spinal cord stimulation on autonomic function in individuals with subacute spinal cord injury: A pilot clinical trial protocol.

PloS one·2026
Same author

Evaluation of pan-alimentary MRI examinations: intrasubject variability and examination duration.

Abdominal radiology (New York)·2026
Same author

Cumulative incidence and risk factors for advanced neoplasia following inflammatory bowel disease-related low-grade dysplasia: a Danish nationwide cohort study.

Journal of Crohn's & colitis·2025
Same author

Transcutaneous vagus nerve stimulation does not affect gastrointestinal function in subjects with diabetic autonomic neuropathy.

Scandinavian journal of gastroenterology·2025

Related Experiment Video

Updated: May 6, 2026

Gastrointestinal Motility Monitor GIMM
08:15

Gastrointestinal Motility Monitor GIMM

Published on: December 1, 2010

34.1K

Rectal motility in pediatric constipation.

Iben Moeller Joensson1, Soren Hagstroem, Lotte Fynne

  • 1*Institute of Clinical Medicine, University of Aarhus †Department of Pediatrics, Aarhus University Hospital, Skejby ‡Neurogastroenterology Unit, Department of Hepatology and Gastroenterology V, Aarhus University, Hospital, Aarhus, Denmark.

Journal of Pediatric Gastroenterology and Nutrition
|October 19, 2013
PubMed
Summary

Children with constipation exhibit prolonged rectal contractions and larger rectal dimensions compared to healthy children. This study utilized rectal impedance planimetry to assess rectal motility and size in pediatric constipation.

More Related Videos

Spatiotemporal Mapping of Motility in Ex Vivo Preparations of the Intestines
12:00

Spatiotemporal Mapping of Motility in Ex Vivo Preparations of the Intestines

Published on: January 27, 2016

13.5K
Diagnosis of Hirschsprung's Disease by Immunostaining Rectal Suction Biopsies for Calretinin, S100 Protein and Protein Gene Product 9.5
05:45

Diagnosis of Hirschsprung's Disease by Immunostaining Rectal Suction Biopsies for Calretinin, S100 Protein and Protein Gene Product 9.5

Published on: April 26, 2019

13.4K

Related Experiment Videos

Last Updated: May 6, 2026

Gastrointestinal Motility Monitor GIMM
08:15

Gastrointestinal Motility Monitor GIMM

Published on: December 1, 2010

34.1K
Spatiotemporal Mapping of Motility in Ex Vivo Preparations of the Intestines
12:00

Spatiotemporal Mapping of Motility in Ex Vivo Preparations of the Intestines

Published on: January 27, 2016

13.5K
Diagnosis of Hirschsprung's Disease by Immunostaining Rectal Suction Biopsies for Calretinin, S100 Protein and Protein Gene Product 9.5
05:45

Diagnosis of Hirschsprung's Disease by Immunostaining Rectal Suction Biopsies for Calretinin, S100 Protein and Protein Gene Product 9.5

Published on: April 26, 2019

13.4K

Area of Science:

  • Pediatric Gastroenterology
  • Gastrointestinal Motility Research
  • Clinical Physiology

Background:

  • Childhood constipation is a prevalent condition with unclear etiological factors.
  • Rectal impedance planimetry offers detailed insights into rectal cross-sectional area (CSA) and pressure, crucial for understanding rectal motility.

Purpose of the Study:

  • To investigate and compare rectal motility patterns between children experiencing constipation and healthy children.
  • To characterize differences in rectal dimensions and compliance using rectal impedance planimetry.

Main Methods:

  • The study involved 10 constipated children (Rome III criteria) and 10 healthy children, aged 8.8 and 9.9 years, respectively.
  • Rectal impedance planimetry measured CSA at three levels, recorded resting motility for 30 minutes, and assessed compliance via distension.
  • Phasic rectal contractions were defined as >10% CSA change from baseline for at least 2 minutes.

Main Results:

  • Constipated children showed significantly longer durations of phasic rectal contractions (median 38%) compared to healthy children (median 8.8%).
  • Rectal CSA was significantly larger in constipated children (median 1802 mm²) versus healthy children (median 1375 mm²).
  • Rectal compliance did not significantly differ between the two groups.

Conclusions:

  • Children with constipation demonstrate a prolonged period of phasic rectal contractions.
  • Constipated children exhibit larger rectal dimensions than their healthy counterparts.
  • These findings suggest altered rectal motility and size contribute to pediatric constipation.